Related Experiment Video
Updated: Dec 13, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Complement in Hemolysis- and Thrombosis- Related Diseases.
Shanshan Luo1, Desheng Hu1,2, Moran Wang1
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
The complement system interacts with platelets and coagulation, influencing immune responses and tissue balance. Dysregulation of this network contributes to various diseases, highlighting complement
Area of Science:
- Immunology and Hematology: Focuses on the intricate interplay between the complement system, platelets, and coagulation within innate immunity and blood circulation.
Background:
- The complement system is a self-regulated network of proteins crucial for immune monitoring and tissue homeostasis.
- It forms a complex network with platelets, coagulation, and fibrinolysis systems in blood circulation.
- Dysregulation of these systems can lead to severe clinical manifestations and disease progression.
Purpose of the Study:
- To review the crosstalk between the complement system, platelets, and coagulation.
- To provide insights into how complement dysfunction contributes to the progression of hematologic diseases.
- To discuss the therapeutic potential of targeting the complement system in hemolytic and thrombotic disorders.
Main Methods:
- Literature review summarizing existing research on the complement system, platelets, and coagulation.
- Analysis of the interconnectedness and regulatory mechanisms within these systems.
- Exploration of clinical manifestations and disease progression linked to dysregulation.
Main Results:
- The complement, platelet, and coagulation systems are intricately linked, mutually activating and regulating each other.
- Complement system dysfunction is a significant factor in the pathogenesis of various hemopathic conditions.
- Therapeutic targeting of the complement system shows promise for treating hemolytic and thrombotic diseases.
Conclusions:
- Understanding the crosstalk between complement, platelets, and coagulation is vital for comprehending immune and homeostatic processes.
- Complement system dysregulation plays a critical role in the development and progression of hematologic disorders.
- Targeting the complement system offers a promising therapeutic strategy for managing complement-mediated hemolytic and thrombotic diseases.
More Related Videos
Related Concept Videos
Complement System
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

